Itaconix raises 2026 revenue outlook after record first-half sales growth

Traders Union
All News
Financial Institutions
Itaconix raises 2026 outlook

Highlights

Itaconix reports unaudited H1 2026 revenue of $8.3 million, up 72% year-on-year and 46% sequentially, driven by growth across all major product segments.
Itaconix raises FY 2026 revenue outlook to at least $14.8 million, ahead of market expectations, and maintains guidance for a small positive EBITDA despite increased investment.
Strong demand for Performance Ingredients and SPARX Formulated Solutions, alongside new specialty product initiatives in paints and agriculture, diversify growth beyond household cleaning.

First-half performance and updated guidance

As reported by London Stock Exchange Regulatory News Service, Itaconix says unaudited revenue for the six months to 30 June 2026 reaches $8.3 million, up 72% from $4.8 million in the first half of 2025 and 46% from $5.7 million in the second half of 2025. The company says growth is achieved across all major product segments, while gross profit margin for H1 2026 is expected to remain in line with FY 2025 at 36% after management of raw materials and supply chains.

The board says revenue for the year to 31 December 2026 is now expected to be no less than $14.8 million, ahead of market expectations. It also continues to expect a small positive EBITDA for FY 2026, despite strategic investment in headcount and product development intended to support near-term expansion and longer-term revenue opportunities.

Further detail on first-half trading is expected in the company’s 2026 interim results, which are due on or about 8 September 2026.

Demand trends across detergents, paints and crop inputs

Performance Ingredients, which mainly serves the dish detergent market, performs strongly in both EMEA and North America. The company says growth is driven by higher reorder volumes from existing customers, alongside a new unit-dose dish detergent customer in EMEA and a new unit-dose laundry detergent customer in North America.

SPARX Formulated Solutions also grows as use of SPARX formulations increases in North America for solid unit-dose dish and laundry detergents. Itaconix says these revenues come from sales of other key ingredients required by contract manufacturers to produce SPARX formulations.

The company is also advancing longer-term opportunities in higher-value end markets through its BIO*Asterix specialty monomers and binders for paints and its BioVail plant nutrition ingredient for crop production. These initiatives broaden Itaconix’s exposure beyond household cleaning into specialty materials and agricultural inputs.

In our earlier article on foreign takeovers of London-listed companies, we noted that overseas buyers have been snapping up UK-listed firms as low valuations and international exposure make them attractive targets. We also highlighted that takeover activity has been far outpacing new listings, adding to concerns about the London market’s shrinking depth and the need for policy measures to restore confidence.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.